Meteora Capital’s Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share VHAQ.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding VHAQ.WS
Meteora Capital's VHAQ.WS Position: Q4 2023 in Review
Meteora Capital sold out of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) in Q4 2023, closing a stake of 82,940 shares — an estimated $1.9K sold.
Meteora Capital first reported a position in VHAQ.WS in Q4 2022 and held it in 4 quarters. The position peaked at $4.02K in Q4 2022. 6 funds tracked by Wall St. Rank hold VHAQ.WS as of Q4 2023.
- Meteora Capital reported no remaining Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position as of Q4 2023 after selling out during the quarter.
- Meteora Capital sold 82,940 Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share shares in Q4 2023, an estimated $1.9K.
- Meteora Capital first reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in Q4 2022 and held it in 4 quarters.
- Meteora Capital's Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position peaked at $4.02K in Q4 2022.
- 6 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share as of Q4 2023.
Based on Meteora Capital's 13F filing for Q4 2023, filed 14 Feb 2024.